1 Jan 2014Article
Axillary lymphadenectomy for breast cancer and fibrin glue
Roberto Ruggiero 1Giovanni Docimo 1Adelmo Gubitosi 1Giovanni Conzo 1Salvatore Tolone 1Simona Gili 1Alfonso Bosco 1Ludovico Docimo 1
Affiliations
Article Info
1 Division of General Surgery, Department of Surgery, Second University of Naples, Naples, Italy
Ann. Ital. Chir., 2014, 85(1), 88-92;
Published: 1 Jan 2014
Copyright © 2014 Annali Italiani di Chirurgia
This work is licensed under a Creative Commons Attribution 4.0 International License.
Abstract
BACKGROUND: Axillary lymphadenectomy or sentinel biopsy is integral part of breast cancer treatment, yet seroma formation occurs in 15-85% of cases. Among methods employed to reduce seroma magnitude and duration, fibrin glue has been proposed in numerous studies with controversial results. METHODS: Eighty patients underwent quadrantectomy or mastectomy with level I/II axillary lymphadenectomy; a suction drain was fitted in all patients. Fibrin glue spray were applied to the axillary fossa in 40 patients; the other 40 patients were treated conventionally. RESULTS: Suction drainage was removed between post-operative Days 3 and 4. Seroma magnitude and duration were significantly reduced (p=0.004 and 0.02, respectively), and there were fewer evacuative punctures, in patients receiving fibrin glue compared with the conventional treatment group. CONCLUSIONS: Use of fibrin glue does not always prevent seroma formation, but does reduce seroma magnitude, duration and necessary evacuative punctures.
Keywords
- Breast cancer
- Fibrin glue
- Seroma